Back to search
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory or Recurrent Solid Tumors, Excluding CNS Tumors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory or Recurrent Solid Tumors, Excluding CNS Tumors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 1, open-label, dose escalation study to evaluate the safety, pharmacokinetics, and antitumor activity of pixantrone in pediatric patients with r…
This is a Phase 1 study of eribulin mesylate in pediatric participants with recurrent or refractory solid tumors (excluding CNS), including lymphomas. Eribulin…
This trial will be the first study of axitinib in children and adolescents. The primary objective of this Phase 1 trial is to determine a maximum tolerated dose…